falcon-980ae294·4 events·first seen Aliases: Falcon, Falcon 3, Falcon 2
FutureHouse, University of Oxford, and Fordham University released Robin, an open-source AI agent that autonomously identifies existing drugs that could treat a given disease by iteratively hypothesizing mechanisms, designing experiments, and ranking drug candidates using literature-search sub-agents. In a demonstration targeting dry age-related macular degeneration, Robin identified two drugs (Y-27632 and Ripasudil) that produced roughly 1.75–2x increases in RPE phagocytosis in human cell experiments. The pipeline uses GPT o4-mini for most language tasks and Claude 3.7 Sonnet for pairwise ranking, with human involvement limited to naming the disease and running lab experiments. The work represents a concrete, experimentally validated instance of agentic AI accelerating drug repurposing research.
Technology Innovation Institute (TII) has released Falcon 2, an 11B parameter language model pretrained on over 5 trillion tokens spanning 11 languages. The release includes both a base language model and a vision-language model (VLM) variant. This represents a significant update to the Falcon model family, expanding multilingual and multimodal capabilities.
The Technology Innovation Institute (TII) has released the Falcon 3 family of open-weights models, announced via the Hugging Face blog. The release continues TII's Falcon lineage of open models and is positioned as a significant update to the series. Details on model sizes, capabilities, and training methodology are covered in the announcement.
TII (Technology Innovation Institute) has published a blog post on Hugging Face introducing Falcon Perception, a multimodal extension of the Falcon model family. The post appears to detail perception capabilities added to the Falcon series, likely covering vision-language or other sensory modalities. As the body content is empty, specific technical details about architecture, benchmarks, or release scope are unavailable from this source.